INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 160 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $282,000 | -34.1% | 5,048 | -39.0% | 0.00% | 0.0% |
Q2 2022 | $428,000 | -77.3% | 8,278 | -68.1% | 0.00% | -75.0% |
Q1 2022 | $1,888,000 | -60.8% | 25,985 | -36.2% | 0.00% | -55.6% |
Q4 2021 | $4,812,000 | -24.4% | 40,700 | -14.3% | 0.01% | -25.0% |
Q3 2021 | $6,369,000 | +10.6% | 47,477 | +33.5% | 0.01% | +20.0% |
Q2 2021 | $5,760,000 | +126.4% | 35,576 | +12.2% | 0.01% | +150.0% |
Q1 2021 | $2,544,000 | +130.4% | 31,704 | +56.3% | 0.00% | +100.0% |
Q4 2020 | $1,104,000 | +115.6% | 20,290 | -21.2% | 0.00% | +100.0% |
Q3 2020 | $512,000 | +18.5% | 25,744 | +25.1% | 0.00% | 0.0% |
Q2 2020 | $432,000 | -19.7% | 20,575 | -53.3% | 0.00% | 0.0% |
Q1 2020 | $538,000 | -38.5% | 44,023 | -26.2% | 0.00% | 0.0% |
Q4 2019 | $875,000 | +79.3% | 59,637 | +63.2% | 0.00% | 0.0% |
Q3 2019 | $488,000 | +62.1% | 36,538 | +247.4% | 0.00% | – |
Q3 2018 | $301,000 | +16.2% | 10,519 | +11.1% | 0.00% | – |
Q2 2018 | $259,000 | -17.0% | 9,464 | -36.0% | 0.00% | – |
Q1 2018 | $312,000 | -44.6% | 14,791 | -34.7% | 0.00% | -100.0% |
Q3 2017 | $563,000 | +181.5% | 22,640 | +81.1% | 0.00% | – |
Q2 2017 | $200,000 | – | 12,503 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |